Structures of Ebola Virus GP and sGP in Complex with Therapeutic Antibodies
暂无分享,去创建一个
L. Zeitlin | J. Pallesen | J. Crowe | E. Saphire | H. Turner | C. D. Murin | M. Fusco | A. Ward | C. Cottrell | K. Andersen | N. de Val | K. Hastie | A. Flyak | K. Andersen | Natalia de Val
[1] Jens Meiler,et al. Web‐accessible molecular modeling with Rosetta: The Rosetta Online Server that Includes Everyone (ROSIE) , 2018, Protein science : a publication of the Protein Society.
[2] Erin E. H. Tran,et al. Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry , 2016, Journal of Virology.
[3] Ben M. Webb,et al. Comparative Protein Structure Modeling Using MODELLER , 2016, Current protocols in bioinformatics.
[4] G. Gao,et al. Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection , 2016, Cell.
[5] U. Baxa,et al. Structural and molecular basis for Ebola virus neutralization by protective human antibodies , 2016, Science.
[6] K. Chandran,et al. Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies , 2016, mBio.
[7] James E. Crowe,et al. Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection , 2016, Cell.
[8] James D. Campbell,et al. Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial , 2016, The Lancet. Infectious diseases.
[9] Keith S Wilson,et al. Privateer: software for the conformational validation of carbohydrate structures , 2015, Nature Structural &Molecular Biology.
[10] John-Arne Røttingen,et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial , 2015, The Lancet.
[11] J. Rucker,et al. Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies , 2015, Journal of Virology.
[12] Pardis C. Sabeti,et al. Monitoring of Ebola Virus Makona Evolution through Establishment of Advanced Genomic Capability in Liberia , 2015, Emerging infectious diseases.
[13] James E. Crowe,et al. Mechanism of Human Antibody-Mediated Neutralization of Marburg Virus , 2015, Cell.
[14] Matthias J. Brunner,et al. Atomic accuracy models from 4.5 Å cryo-electron microscopy data with density-guided iterative local refinement , 2015, Nature Methods.
[15] Nathaniel Echols,et al. EMRinger: Side-chain-directed model and map validation for 3D Electron Cryomicroscopy , 2015, Nature Methods.
[16] X. Qiu,et al. The multiple roles of sGP in Ebola pathogenesis. , 2015, Viral immunology.
[17] X. Qiu,et al. Structures of protective antibodies reveal sites of vulnerability on Ebola virus , 2014, Proceedings of the National Academy of Sciences.
[18] G. Gao,et al. Molecular Characterization of the Monoclonal Antibodies Composing ZMAb: A Protective Cocktail Against Ebola Virus , 2014, Scientific Reports.
[19] Rachel S. G. Sealfon,et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak , 2014, Science.
[20] Mario Roederer,et al. Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge , 2014, Nature Medicine.
[21] J. Strong,et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp™ , 2014, Nature.
[22] J. Ravetch,et al. Type I and type II Fc receptors regulate innate and adaptive immunity , 2014, Nature Immunology.
[23] X. Qiu,et al. Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb , 2013, Scientific Reports.
[24] Dafna M. Abelson,et al. Structural Rearrangement of Ebola Virus VP40 Begets Multiple Functions in the Virus Life Cycle , 2013, Cell.
[25] D. Agard,et al. Electron counting and beam-induced motion correction enable near atomic resolution single particle cryoEM , 2013, Nature Methods.
[26] Brian D. Weitzner,et al. Serverification of Molecular Modeling Applications: The Rosetta Online Server That Includes Everyone (ROSIE) , 2013, PloS one.
[27] K. Katoh,et al. MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability , 2013, Molecular biology and evolution.
[28] Sjors H.W. Scheres,et al. RELION: Implementation of a Bayesian approach to cryo-EM structure determination , 2012, Journal of structural biology.
[29] Lisa Hensley,et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques , 2012, Proceedings of the National Academy of Sciences.
[30] Shaoxia Chen,et al. Prevention of overfitting in cryo-EM structure determination , 2012, Nature Methods.
[31] X. Qiu,et al. Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies , 2012, Science Translational Medicine.
[32] Xueming Li,et al. Fabs enable single particle cryoEM studies of small proteins. , 2012, Structure.
[33] N. Bohorova,et al. Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant , 2011, Proceedings of the National Academy of Sciences.
[34] V. Volchkov,et al. Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs. , 2011, The Journal of infectious diseases.
[35] X. Qiu,et al. Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies. , 2011, Clinical immunology.
[36] Kathryn L. Schornberg,et al. Cathepsin Cleavage Potentiates the Ebola Virus Glycoprotein To Undergo a Subsequent Fusion-Relevant Conformational Change , 2011, Journal of Virology.
[37] Yoshihiro Kawaoka,et al. A Shared Structural Solution for Neutralizing Ebolaviruses , 2011, Nature Structural &Molecular Biology.
[38] Vincent B. Chen,et al. Correspondence e-mail: , 2000 .
[39] E. Saphire,et al. Ebolavirus glycoprotein structure and mechanism of entry. , 2009, Future virology.
[40] Dafna M. Abelson,et al. Techniques and tactics used in determining the structure of the trimeric ebolavirus glycoprotein. , 2009, Acta crystallographica. Section D, Biological crystallography.
[41] D. Baker,et al. Refinement of protein structures into low-resolution density maps using rosetta. , 2009, Journal of molecular biology.
[42] M Radermacher,et al. DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy. , 2009, Journal of structural biology.
[43] Jeffrey J. Gray,et al. Toward high‐resolution homology modeling of antibody Fv regions and application to antibody–antigen docking , 2009, Proteins.
[44] D. Burton,et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor , 2008, Nature.
[45] Ben M. Webb,et al. Comparative Protein Structure Modeling Using MODELLER , 2007, Current protocols in protein science.
[46] D. Burton,et al. Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys , 2007, PLoS pathogens.
[47] Claus-Wilhelm von der Lieth,et al. GlyProt: in silico glycosylation of proteins , 2005, Nucleic Acids Res..
[48] Martin Frank,et al. Carbohydrate Structure Suite (CSS): analysis of carbohydrate 3D structures derived from the PDB , 2004, Nucleic Acids Res..
[49] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[50] A. Sanchez,et al. Disulfide bond assignment of the Ebola virus secreted glycoprotein SGP. , 2004, Biochemical and biophysical research communications.
[51] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[52] N. Grigorieff,et al. Accurate determination of local defocus and specimen tilt in electron microscopy. , 2003, Journal of structural biology.
[53] J. Wilson,et al. Epitopes involved in antibody-mediated protection from Ebola virus. , 2000, Science.
[54] H. Feldmann,et al. The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer. , 1998, Virology.
[55] A. Sanchez,et al. Biochemical Analysis of the Secreted and Virion Glycoproteins of Ebola Virus , 1998, Journal of Virology.
[56] A. Sanchez,et al. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. , 1996, Proceedings of the National Academy of Sciences of the United States of America.